4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Integrated population pharmacokinetic (PopPK) modeling of cabozantinib (C) in patients (pts) with various cancer types including advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Geißler, M.; Nguyen, L. T.; Chapel, S.; Meyer, T.; Cheng, A. L.; El-Khoueiry, A. B.; Kelley, R. K.; Abou-Alfa, G. K.; Lacy, S.
    Oncology Research and Treatment (2019)

    Fulltext@MSK | Save
  • Extended mutational profiling by MSK-IMPACT™ identifies mutations predicting thromboembolic risk in patients with solid tumor malignancy
    Meeting Abstract

    Dunbar, A.; Bolton, K.; Devlin, S. M.; Sanchez-Vega, F.; Gao, J.; Mones, J. V.; Wills, J. M.; Kelly, D.; Farina, M.; Kishore, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Prognostic value of the Memorial Sloan Kettering (MSK) prognostic score (MPS) in pancreatic ductal adenocarcinoma (PDAC)
    Meeting Abstract

    Lebenthal, J.; Zheng, J. T.; Glare, P. A.; O'Reilly, E. M.; Epstein, A. S.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Movement in the wrong direction: Inaccurate change in prognostic understanding and its predictors
    Meeting Abstract

    George, L.; Epstein, A. S.; Prigerson, H. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Atypical RAS mutations in metastatic colorectal cancer
    Journal Article

    Pietrantonio, F.; Yaeger, R.; Schrock, A. B.; Randon, G.; Romero-Cordoba, S.; Rossini, D.; Fucà, G.; Ross, J. S.; Kotani, D.; Madison, R.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Complete response and immune-mediated adverse effects with checkpoint blockade: Treatment of mismatch repair-deficient colorectal neuroendocrine carcinoma
    Journal Article

    Whitman, J.; Kardosh, A.; Diaz, L. Jr; Fong, L.; Hope, T.; Onodera, C.; Joseph, N.; Le, D.; Fisher, G.; Bergsland, E.
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Genomic characterization of ERBB2-driven biliary cancer and a case of response to ado-trastuzumab emtansine
    Journal Article

    Mondaca, S.; Razavi, P.; Xu, C.; Offin, M.; Myers, M.; Scaltriti, M.; Hechtman, J. F.; Bradley, M.; O'Reilly, E. M.; Berger, M. F.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice
    Meeting Abstract

    Engle, D.; Tiriac, H.; Rivera, K.; Pommier, A.; Whalen, S.; Oni, T.; Alagesan, B.; Lee, E.; Yao, M.; Lucito, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Clinical proof of concept for MCLA-128, a bispecific HER2/3 antibody therapy, in NRG1 fusion-positive cancers
    Meeting Abstract

    Schram, A. M.; O'Reilly, E. M.; Somwar, R.; Benayed, R.; Shameem, S.; Chauhan, T.; Torrisi, J.; Ford, J.; Maussang, D.; Wasserman, E.; more...
    Molecular Cancer Therapeutics (2019)

    Fulltext@MSK | Save
  • What if acupuncture were covered by insurance for pain management? A cross-sectional study of cancer patients at one academic center and 11 community hospitals
    Journal Article

    Liou, K. T.; Hung, T. K. W.; Meghani, S. H.; Epstein, A. S.; Li, Q. S.; Romero, S. A. D.; Cohen, R. B.; Mao, J. J.
    Pain Medicine (2019)

    Fulltext@MSK | Save